About Università degli Studi Federico II; Clinica di Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
17
National Cancer Institute, Naples
5
Gruppo Oncologico del Nord-Ovest
2
Clinical Trials at Università degli Studi Federico II; Clinica di Oncologia Medica
During the past decade, Università degli Studi Federico II; Clinica di Oncologia Medica conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on
average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
2003-07-01
2014-11-01
Completed
300
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer
2006-12-01
2012-06-01
Completed
760
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
2004-03-01
2024-11-01
Active, not recruiting
1,294
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
2008-11-01
2024-11-01
Active, not recruiting
800
Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
2008-07-01
Completed
509
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
2001-11-01
2009-11-01
Completed
244
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi Federico II; Clinica di Oncologia Medica"
#1 collaborator was "University of Campania "Luigi Vanvitelli"" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Università degli Studi Federico II; Clinica di Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Università degli Studi Federico II; Clinica di Oncologia Medica" are
"Breast Cancer" (9 trials), "Colorectal Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Advanced Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Università degli Studi Federico II; Clinica di Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Università degli Studi Federico II; Clinica di Oncologia Medica
Most popular intervention types in "Università degli Studi Federico II; Clinica di Oncologia Medica" are "Drug" (23 trials), "Procedure" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "Trastuzumab Emtansine" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Università degli Studi Federico II; Clinica di Oncologia Medica
The vast majority of trials in "Università degli Studi Federico II; Clinica di Oncologia Medica" are
19 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Università degli Studi Federico II; Clinica di Oncologia Medica
Currently, there are NaN active trials in "Università degli Studi Federico II; Clinica di Oncologia Medica".
undefined are not yet recruiting,
2 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Università degli Studi Federico II; Clinica di Oncologia Medica,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Università degli Studi Federico II; Clinica di Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".